Heidelberg, Germany

Guillaume Taglang

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Guillaume Taglang

Introduction

Guillaume Taglang is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the field of bioinformatics and clinical decision support systems. With a total of five patents to his name, Taglang is recognized for his innovative approaches to personalized medicine.

Latest Patents

One of his latest patents is titled "Systems and methods for clinical decision support." This invention focuses on generating personalized treatment guidelines for patients and selecting appropriate treatments based on their unique molecular profiles. It addresses the complexities of cases where patients have multiple actionable aberrations by integrating patient-specific molecular data with treatment-specific information. Another notable patent is "Systems and methods for personalized de-risking based on patient genome data." This patent describes methods for utilizing genomic information to optimize therapy for patients, assessing the likelihood of adverse events when co-prescribing medications.

Career Highlights

Guillaume Taglang works at Molecular Health GmbH, a company dedicated to advancing healthcare through innovative technology. His work has been instrumental in developing systems that enhance clinical decision-making and improve patient outcomes.

Collaborations

Taglang collaborates with notable colleagues, including David B. Jackson and Theodoros Soldatos, contributing to a dynamic research environment that fosters innovation.

Conclusion

Guillaume Taglang's contributions to bioinformatics and clinical decision support systems exemplify the impact of innovation in healthcare. His patents reflect a commitment to improving patient care through personalized medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…